ESR1 and breast cancer: In particular, we recently demonstrated that E2 stimulation rapidly enhances the ERα activity (Ser118 phosphorylation and PI3K/AKT pathway activation) in breast cancer cells increasing the intracellular levels of an anti-apoptotic globin, neuroglobin (NGB) [22].